Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2010 2
2011 2
2015 1
2017 1
2018 2
2019 1
2021 3
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

12 results
Results by year
Filters applied: . Clear all
Page 1
Predictive Immunological, Virological, and Routine Laboratory Markers for Critical COVID-19 on Admission.
García-Gasalla M, Ferrer JM, Fraile-Ribot PA, Ferre-Beltrán A, Rodríguez A, Martínez-Pomar N, Ramon-Clar L, Iglesias A, Losada-López I, Fanjul F, Pou JA, Llompart-Alabern I, Toledo N, Pons J, Oliver A, Riera M, Murillas J. García-Gasalla M, et al. Among authors: pons j. Can J Infect Dis Med Microbiol. 2021 Aug 2;2021:9965850. doi: 10.1155/2021/9965850. eCollection 2021. Can J Infect Dis Med Microbiol. 2021. PMID: 34422145 Free PMC article.
Relapsing-Remitting Multiple Sclerosis Is Characterized by a T Follicular Cell Pro-Inflammatory Shift, Reverted by Dimethyl Fumarate Treatment.
Cunill V, Massot M, Clemente A, Calles C, Andreu V, Núñez V, López-Gómez A, Díaz RM, Jiménez MLR, Pons J, Vives-Bauzà C, Ferrer JM. Cunill V, et al. Among authors: pons j. Front Immunol. 2018 May 29;9:1097. doi: 10.3389/fimmu.2018.01097. eCollection 2018. Front Immunol. 2018. PMID: 29896193 Free PMC article.
Randomized clinical trial to assess the efficacy of a comprehensive programme of secondary prevention of cardiovascular disease in general practice: the PREseAP study.
Brotons C, Soriano N, Moral I, Rodrigo MP, Kloppe P, Rodríguez AI, González ML, Ariño D, Orozco D, Buitrago F, Pepió JM, Borrás I; PREseAP study research team. Brotons C, et al. Rev Esp Cardiol. 2011 Jan;64(1):13-20. doi: 10.1016/j.recesp.2010.07.005. Epub 2010 Dec 30. Rev Esp Cardiol. 2011. PMID: 21194823 Free article. Clinical Trial.
B Cell-Activating Factor. An Orchestrator of Lymphoid Follicles in Severe Chronic Obstructive Pulmonary Disease.
Polverino F, Cosio BG, Pons J, Laucho-Contreras M, Tejera P, Iglesias A, Rios A, Jahn A, Sauleda J, Divo M, Pinto-Plata V, Sholl L, Rosas IO, Agustí A, Celli BR, Owen CA. Polverino F, et al. Among authors: pons j. Am J Respir Crit Care Med. 2015 Sep 15;192(6):695-705. doi: 10.1164/rccm.201501-0107OC. Am J Respir Crit Care Med. 2015. PMID: 26073875 Free PMC article.
Surveillance study on the tolerability and safety of Flebogamma® DIF (10% and 5% intravenous immunoglobulin) in adult and pediatric patients.
Alsina L, Mohr A, Montañés M, Oliver X, Martín E, Pons J, Drewe E, Papke J, Günther G, Chee R, Gompels M; investigators of the Flebogamma DIF PASS Study Group. Alsina L, et al. Among authors: pons j. Pharmacol Res Perspect. 2017 Oct;5(5):e00345. doi: 10.1002/prp2.345. Pharmacol Res Perspect. 2017. PMID: 28971614 Free PMC article.
12 results